Graphite India and Epigral slide as Krsnaa Diagnostics rallies after mixed quarterly earnings
Earnings season brought divergence among midcaps as Graphite India and Epigral declined, while Krsnaa Diagnostics, NALCO, and Torrent Pharma advanced on strong operational guidance and improving margins.